Asymptomatic cardiac toxicity in long-term cancer survivors: defining the population and recommendations for surveillance.

Abstract

Advances in the treatment of pediatric and adult cancer have reduced the mortality rates from these disorders and have led to an ever-increasing population of long-term survivors. Chemotherapy and radiotherapy may cause premature cardiac disease that may be asymptomatic or symptomatic. All patients exposed to chemotherapy with cardiotoxic potential or chest radiotherapy have stage A heart failure and the goal of surveillance and treatment is to prevent progression to stages B-D. Screening strategies, including the use of biomarkers, echocardiography, and expert opinion surveillance and treatment recommendations, are presented.

DOI: 10.1053/j.seminoncol.2013.01.005
05010020132014201520162017
Citations per Year

88 Citations

Semantic Scholar estimates that this publication has 88 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Carver2013AsymptomaticCT, title={Asymptomatic cardiac toxicity in long-term cancer survivors: defining the population and recommendations for surveillance.}, author={Joseph R . Carver and Dava E Szalda and Bonnie Ky}, journal={Seminars in oncology}, year={2013}, volume={40 2}, pages={229-38} }